Avet Pharmaceuticals Inc.
9 drugs in NADAC|9 Generic,0 Brand
Avet Pharmaceuticals Inc. lists 9 NDCs in the CMS NADAC file (9 generic, 0 brand), at an average NADAC of $1.00 per unit, with a week-over-week move of -0.7% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
9
9G / 0B
Avg Price / Unit
$0.9956
$0.14 – $6.65
Avg 7d Change
-0.65%
Across 9 drugs with changes
7d Activity
of 9 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Letrozole Tablets market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Aromatase Inhibitor therapeutic class
Review the broader class where Avet Pharmaceuticals Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Avet Pharmaceuticals Inc. make?
Avet Pharmaceuticals Inc. lists 9 NDCs in the CMS NADAC file — 9 generic and 0 brand products.
What is the average price of Avet Pharmaceuticals Inc. drugs?
The average NADAC across Avet Pharmaceuticals Inc.'s portfolio is $0.9956 per unit, ranging from $0.1416 to $6.6539.
What types of drugs does Avet Pharmaceuticals Inc. make?
Avet Pharmaceuticals Inc. makes drugs across 3 FDA pharmacologic classes. The most common by NDC count are Aromatase Inhibitor (6), Monoamine Oxidase Inhibitor (2), Antimalarial (1).
Has Avet Pharmaceuticals Inc. had any drug recalls?
No FDA enforcement recalls are matched to Avet Pharmaceuticals Inc. in the openFDA feed.
How has Avet Pharmaceuticals Inc.'s pricing changed recently?
Over the past 7 days, 4 Avet Pharmaceuticals Inc. products rose and 5 fell, with a portfolio-wide average change of -0.7%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CHLOROQUINE PH 500 MG TABLET Chloroquine Phosphate | $6.6539 per EA | -1.30% |
RASAGILINE MESYLATE 1 MG TAB Rasagiline mesylate | $0.9255 per EA | -10.31% |
RASAGILINE MESYLATE 0.5 MG TAB Rasagiline mesylate | $0.5209 per EA | +14.59% |
LETROZOLE 2.5 MG TABLET Letrozole Tablets | $0.1450 per EA | -4.06% |
LETROZOLE 2.5 MG TABLET Letrozole Tablets | $0.1450 per EA | -4.06% |
LETROZOLE 2.5 MG TABLET Letrozole Tablets | $0.1450 per EA | -4.06% |
ANASTROZOLE 1 MG TABLET Anastrozole Tablets | $0.1416 per EA | +1.11% |
ANASTROZOLE 1 MG TABLET Anastrozole Tablets | $0.1416 per EA | +1.11% |
ANASTROZOLE 1 MG TABLET Anastrozole Tablets | $0.1416 per EA | +1.11% |